Increased brain iron in patients with thyroid-associated ophthalmopathy: a whole-brain analysis

Front Endocrinol (Lausanne). 2023 Nov 16:14:1268279. doi: 10.3389/fendo.2023.1268279. eCollection 2023.

Abstract

Background: To investigate the whole-brain iron deposition alternations in patients with thyroid-associated ophthalmopathy (TAO) using quantitative susceptibility mapping (QSM).

Methods: Forty-eight patients with TAO and 33 healthy controls (HCs) were enrolled. All participants underwent brain magnetic resonance imaging scans and clinical scale assessments. QSM values were calculated and compared between TAO and HCs groups using a voxel-based analysis. A support vector machine (SVM) analysis was performed to evaluate the performance of QSM values in differentiating patients with TAO from HCs.

Results: Compared with HCs, patients with TAO showed significantly increased QSM values in the bilateral caudate nucleus (CN), left thalamus (TH), left cuneus, left precuneus, right insula and right middle frontal gyrus. In TAO group, QSM values in left TH were positively correlated with Hamilton Depression Rating Scale (HDRS) scores (r = 0.414, p = 0.005). The QSM values in right CN were negatively correlated with Montreal Cognitive Assessment (MoCA) scores (r = -0.342, p = 0.021). Besides that, a nearly negative correlation was found between QSM values in left CN and MoCA scores (r = -0.286, p = 0.057). The SVM model showed a good performance in distinguishing patients with TAO from the HCs (area under the curve, 0.958; average accuracy, 90.1%).

Conclusion: Patients with TAO had significantly increased iron deposition in brain regions corresponding to known visual, emotional and cognitive deficits. QSM values could serve as potential neuroimaging markers of TAO.

Keywords: brain iron deposition; deep gray matter; magnetic resonance imaging; quantitative susceptibility mapping; thyroid-associated ophthalmopathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain / diagnostic imaging
  • Brain Mapping
  • Cognitive Dysfunction*
  • Graves Ophthalmopathy* / diagnostic imaging
  • Humans
  • Iron

Substances

  • Iron

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by National Natural Science Foundation of China (NSFC) (81801659 to HH), Jiangsu Province Capability Improvement Project through Science, Technology and Education (JSDW202243 to F-YW), and Jiangsu Province Hospital (the First Affiliated Hospital with Nanjing Medical University) Clinical Capability Enhancement Project (JSPH-MC-2021-8 to X-QX).